WNT/RYK signaling restricts goblet cell differentiation during lung development and repair.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
17 12 2019
Historique:
pubmed: 30 11 2019
medline: 14 4 2020
entrez: 29 11 2019
Statut: ppublish

Résumé

Goblet cell metaplasia and mucus hypersecretion are observed in many pulmonary diseases, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. However, the regulation of goblet cell differentiation remains unclear. Here, we identify a regulator of this process in an

Identifiants

pubmed: 31776260
pii: 1911071116
doi: 10.1073/pnas.1911071116
pmc: PMC6926051
doi:

Substances chimiques

beta Catenin 0
RYK protein, human EC 2.7.10.1
Receptor Protein-Tyrosine Kinases EC 2.7.10.1
Ryk protein, mouse EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

25697-25706

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

J Cell Biol. 2008 Sep 22;182(6):1073-82
pubmed: 18809723
Am J Respir Crit Care Med. 2014 Feb 1;189(3):301-13
pubmed: 24392884
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3226-3242
pubmed: 28866134
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3121-3126
pubmed: 28270600
J Cell Biol. 2010 Jul 26;190(2):263-78
pubmed: 20660632
Trends Neurosci. 2010 Feb;33(2):84-92
pubmed: 20004982
Dev Biol. 2009 Oct 1;334(1):97-108
pubmed: 19631635
Trends Mol Med. 2015 Aug;21(8):492-503
pubmed: 26144290
Nature. 2006 Jan 5;439(7072):31-7
pubmed: 16280981
J Biochem. 2015 Nov;158(5):355-65
pubmed: 26261051
Eur Respir J. 2015 Oct;46(4):1150-66
pubmed: 25929950
Am J Respir Cell Mol Biol. 2004 Oct;31(4):382-94
pubmed: 15191915
Lab Invest. 1992 Nov;67(5):553-65
pubmed: 1434534
Pharmacol Ther. 2018 May;185:155-169
pubmed: 29287707
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16287-92
pubmed: 19805295
Development. 2008 Oct;135(19):3247-57
pubmed: 18776145
Cell. 2004 Oct 1;119(1):97-108
pubmed: 15454084
Nature. 1999 Dec 2;402(6761):540-4
pubmed: 10591215
Am J Respir Cell Mol Biol. 2018 Sep;59(3):383-396
pubmed: 29579396
J Cell Biol. 2011 Sep 5;194(5):737-50
pubmed: 21875946
J Biol Chem. 2012 Dec 28;287(53):44518-25
pubmed: 23144463
Development. 2009 May;136(10):1751-9
pubmed: 19369400
Annu Rev Cell Dev Biol. 2011;27:493-512
pubmed: 21639799
Mediators Inflamm. 2017;2017:3520581
pubmed: 28588349
Exp Lung Res. 2013 May-Jun;39(4-5):207-16
pubmed: 23638644
Nat Commun. 2018 Jul 19;9(1):2815
pubmed: 30022023
PLoS One. 2011 Apr 07;6(4):e14793
pubmed: 21490961
Thorax. 2017 Aug;72(8):746-759
pubmed: 28416592
Am J Respir Crit Care Med. 2011 Mar 15;183(6):723-33
pubmed: 20889911
Am J Respir Cell Mol Biol. 2013 Mar;48(3):364-73
pubmed: 23239495
Nat Commun. 2018 Nov 2;9(1):4600
pubmed: 30389913
Respir Res. 2016 Apr 23;17:44
pubmed: 27107715
Dev Biol. 2015 Oct 15;406(2):222-34
pubmed: 26321050
Development. 2005 Mar;132(6):1363-74
pubmed: 15716345
Chest. 2018 Jul;154(1):169-176
pubmed: 29170036
Annu Rev Physiol. 2008;70:487-512
pubmed: 17988208
Dev Cell. 2018 Mar 26;44(6):679-693.e5
pubmed: 29587142
Lab Invest. 2016 Feb;96(2):218-29
pubmed: 26322419
Dev Biol. 2002 Aug 1;248(1):68-81
pubmed: 12142021
BMC Dev Biol. 2012 Jul 30;12:21
pubmed: 22846383
Dev Cell. 2009 Aug;17(2):290-8
pubmed: 19686689
Am J Respir Cell Mol Biol. 2010 Mar;42(3):268-75
pubmed: 19520914
Cold Spring Harb Perspect Biol. 2014 Feb 01;6(2):null
pubmed: 24370848
J Thorac Cardiovasc Surg. 2014 Jul;148(1):322-32
pubmed: 24280717
Growth Factors. 2018 Apr;36(1-2):58-68
pubmed: 30035654
Development. 2012 Jul;139(14):2500-9
pubmed: 22675208
Growth Factors. 2018 Apr;36(1-2):15-40
pubmed: 29806777
J Clin Invest. 2006 Feb;116(2):306-8
pubmed: 16453018
J Biol Chem. 2012 Aug 24;287(35):29312-23
pubmed: 22773843
J Clin Invest. 2015 May;125(5):2021-31
pubmed: 25866971
J Clin Invest. 2007 Apr;117(4):978-88
pubmed: 17347682
Nat Genet. 2000 Aug;25(4):414-8
pubmed: 10932185
Development. 2018 Jun 8;145(11):
pubmed: 29884654
J Biol Chem. 2015 Nov 20;290(47):28428-37
pubmed: 26442586
Am J Physiol Lung Cell Mol Physiol. 2005 Dec;289(6):L971-9
pubmed: 16040629
Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):6842-6847
pubmed: 28607090
Annu Rev Physiol. 2008;70:405-29
pubmed: 17961085

Auteurs

Hyun-Taek Kim (HT)

Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany; Hyun-Taek.Kim@mpi-bn.mpg.de didier.stainier@mpi-bn.mpg.de.

Wenguang Yin (W)

Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.

Yuko Nakamichi (Y)

Institute for Oral Science, Matsumoto Dental University, 399-0781 Shiojiri, Japan.

Paolo Panza (P)

Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.

Beate Grohmann (B)

Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.

Carmen Buettner (C)

Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.

Stefan Guenther (S)

Bioinformatics and Deep Sequencing Platform, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.

Clemens Ruppert (C)

Biobank, University of Giessen & Marburg Lung Center, 35392 Giessen, Germany.

Yasuhiro Kobayashi (Y)

Institute for Oral Science, Matsumoto Dental University, 399-0781 Shiojiri, Japan.

Andreas Guenther (A)

Biobank, University of Giessen & Marburg Lung Center, 35392 Giessen, Germany.

Didier Y R Stainier (DYR)

Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany; Hyun-Taek.Kim@mpi-bn.mpg.de didier.stainier@mpi-bn.mpg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH